1skj
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1skj.gif|left|200px]] | [[Image:1skj.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1skj", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | | | + | --> |
| - | | | + | {{STRUCTURE_1skj| PDB=1skj | SCENE= }} |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX''' | '''COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX''' | ||
| Line 28: | Line 25: | ||
[[Category: Holland, D R.]] | [[Category: Holland, D R.]] | ||
[[Category: Rubin, J R.]] | [[Category: Rubin, J R.]] | ||
| - | [[Category: | + | [[Category: Peptidomimetic]] |
| - | [[Category: | + | [[Category: Phosphotyrosine recognition domain]] |
| - | [[Category: | + | [[Category: Pp60 src sh2 domain]] |
| - | [[Category: | + | [[Category: Tyrosine-protein kinase]] |
| - | [[Category: | + | [[Category: Ureido]] |
| - | [[Category: | + | [[Category: V-src sh2 domain]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 08:48:59 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 05:49, 3 May 2008
COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX
Overview
The specific association of an SH2 domain with a phosphotyrosine (pTyr)-containing sequence of another protein precipitates a cascade of intracellular molecular interactions (signals) which effect a wide range of intracellular processes. The nonreceptor tyrosine kinase Src, which has been associated with breast cancer and osteoporosis, contains an SH2 domain. Inhibition of Src SH2-phosphoprotein interactions by small molecules will aid biological proof-of-concept studies which may lead to the development of novel therapeutic agents. Structure-based design efforts have focused on reducing the size and charge of Src SH2 ligands while increasing their ability to penetrate cells and reach the intracellular Src SH2 domain target. In this report we describe the synthesis, binding affinity, and Src SH2 cocrystal structure of a small, novel, nonpeptide, urea-containing SH2 domain ligand.
About this Structure
1SKJ is a Single protein structure of sequence from Rous sarcoma virus. Full crystallographic information is available from OCA.
Reference
Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand., Plummer MS, Holland DR, Shahripour A, Lunney EA, Fergus JH, Marks JS, McConnell P, Mueller WT, Sawyer TK, J Med Chem. 1997 Nov 7;40(23):3719-25. PMID:9371236 Page seeded by OCA on Sat May 3 08:48:59 2008
